<DOC>
	<DOCNO>NCT02852824</DOCNO>
	<brief_summary>The primary objective trial investigate safety tolerability BI 655130 healthy male subject follow IV administration multiple rise dos . The study also explore safety tolerability follow single IV administration .</brief_summary>
	<brief_title>Study Investigate Safety , Tolerability , Pharmacokinetics Pharmacodynamics BI 655130 Healthy Male Volunteers</brief_title>
	<detailed_description />
	<criteria>Inclusion criterion : Healthy male subject accord investigator ` assessment , base complete medical history include physical examination , vital sign ( BP Blood Pressure , PR Pulse Rate ) , 12lead ECG ( Electrocardiogram ) , clinical laboratory test Age 18 50 year ( incl . ) BMI 18.5 29.9 kg/m2 ( incl . ) Signed date write informed consent prior admission study accordance GCP local legislation Exclusion criterion : Any find medical examination ( include BP Blood Pressure , PR Pulse Rate ECG Electrocardiogram ) deviate normal judge clinically relevant investigator Repeated measurement systolic blood pressure outside range 90 140 mmHg , diastolic blood pressure outside range 50 90 mmHg , pulse rate outside range 45 90 bpm Any laboratory value outside reference range investigator considers clinical relevance Any evidence concomitant disease judge clinically relevant investigator Gastrointestinal , hepatic , renal , respiratory , cardiovascular , metabolic , immunological hormonal disorder Diseases central nervous system ( include limit kind seizure stroke ) , relevant neurological psychiatric disorder History relevant orthostatic hypotension , faint spell , blackouts Further exclusion criterion apply</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>